Search

John Kwon

Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )

Most Active Art Unit
3747
Art Unit(s)
2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622
Total Applications
4781
Issued Applications
4291
Pending Applications
92
Abandoned Applications
420

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17267467 [patent_doc_number] => 11192878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => Piperidine-2,6-dione derivative and use thereof [patent_app_type] => utility [patent_app_number] => 16/609805 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15752 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609805 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609805
Piperidine-2,6-dione derivative and use thereof May 10, 2018 Issued
Array ( [id] => 16090283 [patent_doc_number] => 20200199128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES AS KINASE JAK INHIBITORS [patent_app_type] => utility [patent_app_number] => 16/609891 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609891 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609891
Pyrazole[1,5-a] pyrimidine derivatives as kinase JAK inhibitors May 9, 2018 Issued
Array ( [id] => 15740531 [patent_doc_number] => 20200109153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS [patent_app_type] => utility [patent_app_number] => 16/611538 [patent_app_country] => US [patent_app_date] => 2018-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611538 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611538
HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS May 7, 2018 Abandoned
Array ( [id] => 13399817 [patent_doc_number] => 20180251451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => INDOLIN-2-ONE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 15/971399 [patent_app_country] => US [patent_app_date] => 2018-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971399 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/971399
Indolin-2-one derivatives May 3, 2018 Issued
Array ( [id] => 17251082 [patent_doc_number] => 11186554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-30 [patent_title] => Non-fused tricyclic compounds [patent_app_type] => utility [patent_app_number] => 16/609715 [patent_app_country] => US [patent_app_date] => 2018-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 102426 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609715
Non-fused tricyclic compounds May 1, 2018 Issued
Array ( [id] => 16141317 [patent_doc_number] => 10703719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Method for producing 5-hydroxypiperidine-2-carboxylic acid [patent_app_type] => utility [patent_app_number] => 15/965289 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20506 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965289 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/965289
Method for producing 5-hydroxypiperidine-2-carboxylic acid Apr 26, 2018 Issued
Array ( [id] => 14664881 [patent_doc_number] => 10370330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Method for producing 5-hydroxypiperidine-2-carboxylic acid [patent_app_type] => utility [patent_app_number] => 15/965316 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20557 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965316 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/965316
Method for producing 5-hydroxypiperidine-2-carboxylic acid Apr 26, 2018 Issued
Array ( [id] => 15893549 [patent_doc_number] => 20200146293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES [patent_app_type] => utility [patent_app_number] => 16/609631 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27990 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609631 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609631
2-(het)aryl-substituted fused heterocycle derivatives as pesticides Apr 24, 2018 Issued
Array ( [id] => 16072115 [patent_doc_number] => 20200190044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => COMPOUNDS HAVING ANTIINFECTIVE, ANTITUMORAL AND ANTIFUNGAL ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/608268 [patent_app_country] => US [patent_app_date] => 2018-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608268 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/608268
Compounds having antiinfective, antitumoral and antifungal activity Apr 24, 2018 Issued
Array ( [id] => 15451107 [patent_doc_number] => 20200038377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-06 [patent_title] => INHIBITION OF PROTEIN DISULFIDE-ISOMERASE A3 [patent_app_type] => utility [patent_app_number] => 16/605978 [patent_app_country] => US [patent_app_date] => 2018-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605978 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/605978
Inhibition of protein disulfide-isomerase A3 Apr 16, 2018 Issued
Array ( [id] => 16870002 [patent_doc_number] => 20210163469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => SMALL MOLECULES [patent_app_type] => utility [patent_app_number] => 16/604737 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604737 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604737
Small molecules Apr 12, 2018 Issued
Array ( [id] => 13342759 [patent_doc_number] => 20180222919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => N-ALKYL-2-PHENOXYETHANAMINES, THEIR PREPARATION AND USE [patent_app_type] => utility [patent_app_number] => 15/944334 [patent_app_country] => US [patent_app_date] => 2018-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -115 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944334 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/944334
N-alkyl-2-phenoxyethanamines, their preparation and use Apr 2, 2018 Issued
Array ( [id] => 15850457 [patent_doc_number] => 10640494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof [patent_app_type] => utility [patent_app_number] => 15/942345 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 29915 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15942345 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/942345
N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof Mar 29, 2018 Issued
Array ( [id] => 13476355 [patent_doc_number] => 20180289720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => COMPOUNDS THAT INHIBIT MCL-1 PROTEIN [patent_app_type] => utility [patent_app_number] => 15/938001 [patent_app_country] => US [patent_app_date] => 2018-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 104226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938001 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/938001
Compounds that inhibit MCL-1 protein Mar 27, 2018 Issued
Array ( [id] => 17634964 [patent_doc_number] => 11345676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds [patent_app_type] => utility [patent_app_number] => 16/497695 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34419 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 422 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497695 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/497695
Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds Mar 22, 2018 Issued
Array ( [id] => 16688271 [patent_doc_number] => 20210070747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => 2(1H)-QUINOLINONE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 16/496066 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 749 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496066 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496066
2(1H)-QUINOLINONE DERIVATIVE Mar 22, 2018 Abandoned
Array ( [id] => 15435153 [patent_doc_number] => 20200031760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => BUILDING BLOCKS FOR STAPLED PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/497299 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10670 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -61 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497299 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/497299
Building blocks for stapled peptides Mar 22, 2018 Issued
Array ( [id] => 13986237 [patent_doc_number] => 20190062276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer [patent_app_type] => utility [patent_app_number] => 15/927426 [patent_app_country] => US [patent_app_date] => 2018-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927426 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/927426
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer Mar 20, 2018 Abandoned
Array ( [id] => 13521927 [patent_doc_number] => 20180312506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-01 [patent_title] => 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS [patent_app_type] => utility [patent_app_number] => 15/927170 [patent_app_country] => US [patent_app_date] => 2018-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32845 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927170 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/927170
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Mar 20, 2018 Issued
Array ( [id] => 15649467 [patent_doc_number] => 20200087263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => 5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS [patent_app_type] => utility [patent_app_number] => 16/494433 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494433 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494433
5-carboxamide-2-thiobarbituric acids and use thereof as medicaments Mar 14, 2018 Issued
Menu